Growth Metrics

Bio-Rad Laboratories (BIO) Cash from Investing Activities Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -253.01%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -11.91%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -41.67%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -6.88%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -472.46%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -16.93%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -111.03%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -40.94%
10 Bio-Rad Laboratories 8.23 Bn 6.66 Bn 309.40 Mn -9.77%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -9.77%
Dec 31, 2025 16.41%
Sep 30, 2025 21.36%
Jun 30, 2025 7.22%
Mar 31, 2025 26.06%
Dec 31, 2024 62.26%
Sep 30, 2024 11.86%
Jun 30, 2024 32.46%
Mar 31, 2024 3.74%
Dec 31, 2023 47.48%
Sep 30, 2023 -28.15%
Jun 30, 2023 32.30%
Mar 31, 2023 -78.35%
Dec 31, 2022 1.46%
Sep 30, 2022 7.00%
Jun 30, 2022 -112.43%
Mar 31, 2022 -242.95%
Dec 31, 2021 -117.95%
Sep 30, 2021 -40.22%
Jun 30, 2021 -6.15%
Mar 31, 2021 -36.95%
Dec 31, 2020 -65.92%
Sep 30, 2020 101.10%
Jun 30, 2020 -33.43%
Mar 31, 2020 51.72%
Dec 31, 2019 -6.88%
Sep 30, 2019 -27.18%
Jun 30, 2019 36.72%
Mar 31, 2019 23.56%
Dec 31, 2018 13.19%
Sep 30, 2018 -2.71%
Jun 30, 2018 -44.37%
Mar 31, 2018 12.40%
Dec 31, 2017 35.80%
Sep 30, 2017 31.71%
Jun 30, 2017 14.18%
Mar 31, 2017 -45.87%
Dec 31, 2016 -8.31%
Sep 30, 2016 -32.10%
Jun 30, 2016 -31.28%
Mar 31, 2016 22.27%
Dec 31, 2015 -12.01%
Sep 30, 2015 36.01%
Jun 30, 2015 43.01%
Mar 31, 2015 31.29%
Dec 31, 2014 34.06%
Sep 30, 2014 5.90%
Jun 30, 2014 9.95%
Mar 31, 2014 22.79%
Dec 31, 2013 8.86%
Sep 30, 2013 69.33%
Jun 30, 2013 -0.19%
Mar 31, 2013 -12.03%
Dec 31, 2012 -38.19%
Sep 30, 2012 -7.96%